Eternity Insights can provide a deep dive research report highlighting the market and competitive in-telligence across the key segments of the market. The report also considers the impact of COVID-19 on the global Computational Biology market. The report considers 2018-2020 historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the mar-ket drivers, challenges, and trends to accurately map the market scenario and competition.
Computational Biology market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
To learn more about this report
The Computational Biology market is estimated to expand at a considerable growth rate during the forecast period ow-ing to increasing prevalence of venous diseases and increasing new product approvals to cater this demand. Rise in the awareness about the diseases, increasing importance of early diagnosis, and growing spending on chronic diseases are poised to boost the market growth. Moreover, the key players in the market are investing in research and development of technologically advanced products leading to increased utilization of the Computational Biology products across developed and developing countries of the world.
Limited awareness about the diseases, high cost of products, low economical condition, and lack of favorable insurance systems restricts the adoption of Computational Biology products across developing regions of the globe. However, launch of new products with low cost and increasing efforts for market penetration in these regions can offer lucrative growth opportunities for the players in the Computational Biology market.
To learn more about this report
Increasing research and development spending on Computational Biology development has been the leading industry trend of Computational Biology market
The leading players in the market are focused on developing products which are cost effective and high quality to tap the huge unaddressed opportunities in the developing regions. This can be wit-nessed from the increasing spending on research and development and growing number of new product approvals.
To learn more about this report
| Report Attributes | Details |
| The market size value in 2021 | USD XX.XX Million |
| CAGR (2021 - 2028) | XX.XX % |
| The Revenue forecast in 2028 | USD XX.XX Million |
| Base year for estimation | 2021 |
| Historical data | 2018-2019 |
| Forecast period | 2022-2028 |
| Quantitative units |
|
| Report coverage | Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered | By Type Outlook, Application Outlook, Regional Outlook |
| By Type Outlook | In-House, Contract, Other |
| By Application Outlook | Cellular & Biological Simulation, Pharmacogenomics, Drug Discovery, Drug Development, Lead Optimization, Lead Discovery, Pharmacokinetics, Disease Modeling, Clinical Trials |
| Regional scope | North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Country scope | U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
| Key companies profiled | Chemical Computing, Accelrys, Certara, Compugen, Entelos, Insilico Pharmaceuticals & Healthcare, Genedata, Leadscope, Simulation Plus, Schrodinger, Rhenovia Pharma, Nimbus Discovery |
| Customization Available | Yes, the report can be tailored to meet your specific requirements. |
1 Methodology and Scope
1.1 Market segmentation & scope
1.2 Information Procurement
1.2.1 Purchased Database
1.2.2 Eternity’s Internal Database
1.2.3 Secondary sources & third-party perspectives
1.2.4 Primary Research
1.3 Information analysis
1.4 Market formulation & data visualization
1.5 Data validation & publishing
2 Executive Summary
3 Computational Biology Market Variables, Trends & Scope
3.1 Market Dynamics
3.1.1 Market Driver Analysis
3.1.2 Market Restraints
3.1.3 Market Challenge Analysis
3.1.4 Market Opportunities
3.1.5 Micro & Macro Indicator
3.2 Impact of COVID-19 Pandemic on Global Computational Biology Market
3.2.1 Overview of Changing Landscape
3.2.2 Pre-covid & Post-Covid Market Analysis
3.3 Market Attractiveness Analysis
3.4 Regulatory Scenario
3.5 Industry Trend Analysis- Historic and Future Trend Assessment
3.6 Merger & Acquisition
3.7 New System Launch/Approvals
3.8 Market Analysis Tools
3.8.1 Porter’s Five Forces
3.8.2 PEST Analysis
3.8.3 Value Chain Analysis
3.9 Key Company Ranking Analysis, 2020
4 Global Computational Biology Market Analysis and Forecast, By Type
4.1 Overview & Definition
4.2 Key Trends
4.3 Global Computational Biology Market Value (US$ Mn) Forecast, by Type (2019 – 2028)
4.2.1 In-House
4.2.2 Contract
4.2.3 Other
4.4 Type Comparison Matrix
4.5 Global Computational Biology Market Attractiveness, By Type
5 Global Computational Biology Market Analysis and Forecast, By Application
5.1 Overview & Definition
5.2 Key Trends
5.3 Global Computational Biology Market Value (US$ Mn) Forecast, by Application (2019 – 2028)
5.3.1 Cellular & Biological Simulation
5.3.2 Pharmacogenomics
5.3.3 Drug Discovery
5.3.4 Drug Development
5.3.5 Lead Optimization
5.3.6 Lead Discovery
5.3.7 Pharmacokinetics
5.3.8 Disease Modeling
5.3.9 Clinical Trials
5.4 Application Comparison Matrix
5.5 Global Computational Biology Market Attractiveness, by Application
6 Global Computational Biology Market Analysis and Forecast, By Region
6.1 Overview & Definition
6.2 Key Trends
6.3 Global Computational Biology Market Value (US$ Mn) Forecast, by Region (2019 – 2028)
6.4 North America
6.5 Europe
6.6 Asia Pacific
6.7 Latin America
6.8 Middle East & Africa
7 Global Computational Biology Market Attractiveness, by Region
8 North America Computational Biology Market Analysis and Forecast
8.1 Key Findings
8.2 North America Computational Biology Market Analysis (US$ Mn) and Forecast, By Type (2019-2028)
8.2.1 In-House
8.2.2 Contract
8.2.3 Other
8.3 North America Computational Biology Market Analysis (US$ Mn) and Forecast, By Application (2019-2028)
8.3.1 Cellular & Biological Simulation
8.3.2 Pharmacogenomics
8.3.3 Drug Discovery
8.3.4 Drug Development
8.3.5 Lead Optimization
8.3.6 Lead Discovery
8.3.7 Pharmacokinetics
8.3.8 Disease Modeling
8.3.9 Clinical Trials
8.4 North America Computational Biology Market Analysis (US$ Mn) and Forecast, By Country (2019-2028)
8.4.1 U.S.
8.4.2 Canada
8.4.3 Rest of North America
8.5 North America Computational Biology Market Attractiveness Analysis
8.5.1 By Type
8.5.2 By Application
8.5.3 By Country
9 Europe Computational Biology Market Analysis and Forecast
9.1 Key Findings
9.2 Europe Computational Biology Market Analysis (US$ Mn) and Forecast, By Type (2019-2028)
9.2.1 In-House
9.2.2 Contract
9.2.3 Other
9.3 Europe Computational Biology Market Analysis (US$ Mn) and Forecast, By Application (2019-2028)
9.3.1 Cellular & Biological Simulation
9.3.2 Pharmacogenomics
9.3.3 Drug Discovery
9.3.4 Drug Development
9.3.5 Lead Optimization
9.3.6 Lead Discovery
9.3.7 Pharmacokinetics
9.3.8 Disease Modeling
9.3.9 Clinical Trials
9.4 Europe Computational Biology Market Analysis (US$ Mn) and Forecast, By Country (2019-2028)
9.4.1 U.K.
9.4.2 Germany
9.4.3 France
9.4.4 Italy
9.4.5 Rest of Europe
9.5 Europe Computational Biology Market Attractiveness Analysis
9.5.1 By Type
9.5.2 By Application
9.5.3 By Country
10 Asia Pacific Computational Biology Market Analysis and Forecast
10.1 Key Findings
10.2 Asia Pacific Computational Biology Market Analysis (US$ Mn) and Forecast, By Type (2019-2028)
10.2.1 In-House
10.2.2 Contract
10.2.3 Other
10.3 Asia Pacific Computational Biology Market Analysis (US$ Mn) and Forecast, By Application (2019-2028)
10.3.1 Cellular & Biological Simulation
10.3.2 Pharmacogenomics
10.3.3 Drug Discovery
10.3.4 Drug Development
10.3.5 Lead Optimization
10.3.6 Lead Discovery
10.3.7 Pharmacokinetics
10.3.8 Disease Modeling
10.3.9 Clinical Trials
10.4 Asia Pacific Computational Biology Market Analysis (US$ Mn) and Forecast, By Country (2019-2028)
10.4.1 China
10.4.2 India
10.4.3 Japan
10.4.4 South Korea
10.4.5 Rest of APAC
10.5 Asia Pacific Computational Biology Market Attractiveness Analysis
10.5.1 By Type
10.5.2 By Application
10.5.3 By Country
11 Latin America Computational Biology Market Analysis and Forecast
11.1 Key Findings
11.2 Latin America Computational Biology Market Analysis (US$ Mn) and Forecast, By Type (2019-2028)
11.2.1 In-House
11.2.2 Contract
11.2.3 Other
11.3 Latin America Computational Biology Market Analysis (US$ Mn) and Forecast, By Application (2019-2028)
11.3.1 Cellular & Biological Simulation
11.3.2 Pharmacogenomics
11.3.3 Drug Discovery
11.3.4 Drug Development
11.3.5 Lead Optimization
11.3.6 Lead Discovery
11.3.7 Pharmacokinetics
11.3.8 Disease Modeling
11.3.9 Clinical Trials
11.4 Latin America Computational Biology Market Analysis (US$ Mn) and Forecast, By Country (2019-2028)
11.4.1 Brazil
11.4.2 Rest of Latin America China
11.5 Latin America Computational Biology Market Attractiveness Analysis
11.5.1 By Type
11.5.2 By Application
11.5.3 By Country
12 Middle East & Africa (MEA) Computational Biology Market Analysis and Forecast
12.1 Key Findings
12.2 Middle East & Africa (MEA) Computational Biology Market Analysis (US$ Mn) and Forecast, By Product Type (2019-2028)
12.2.1 In-House
12.2.2 Contract
12.2.3 Other
12.3 Middle East & Africa (MEA) Computational Biology Market Analysis (US$ Mn) and Forecast, By Application (2019-2028)
12.3.1 Cellular & Biological Simulation
12.3.2 Pharmacogenomics
12.3.3 Drug Discovery
12.3.4 Drug Development
12.3.5 Lead Optimization
12.3.6 Lead Discovery
12.3.7 Pharmacokinetics
12.3.8 Disease Modeling
12.3.9 Clinical Trials
12.4 Middle East & Africa (MEA) Computational Biology Market Analysis (US$ Mn) and Forecast, By Country (2019-2028)
12.4.1 GCC Countries
12.4.2 South Africa
12.4.3 Rest of MEA
12.5 Middle East & Africa (MEA) Computational Biology Market Attractiveness Analysis
12.5.1 By Type
12.5.2 By Application
12.5.3 By Country
13 Competitive Landscape
13.1 Market Players – Competition Matrix
13.2 Market Share Analysis by Key Players, 2020 (%)
13.3 Company Profiles
13.3.1 Chemical Computing
13.3.1.1 Company Overview
13.3.1.2 Company Snapshot
13.3.1.3 Financial Overview
13.3.1.4 Product Portfolio
13.3.1.5 Key Developments/Strategies
13.3.2 Accelrys
13.3.3 Certara
13.3.4 Compugen
13.3.5 Entelos
13.3.6 Insilico Pharmaceuticals & Healthcare
13.3.7 Genedata
13.3.8 Leadscope
13.3.9 Simulation Plus
13.3.10 Schrodinger
13.3.11 Rhenovia Pharma
13.3.12 Nimbus Discovery
14 Key Takeaways
Choose License Type